Qiang Ren
State Key Laboratory Of Natural Medicines, Nanjing 210009, PR China
Puerto Rico
Puerto Rico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Selective Visualization of ROR1-Positive TNBC of the Mesenchymal-Like Subtype Using Peptide-Based 68Ga-PET Radiotracers.
Journal: Journal of medicinal chemistry
Published: June 29, 2026
Discovery of Novel SHP2 ATTEC Degraders against Pancreatic Ductal Adenocarcinoma Harboring KRAS(G12D) Mutations.
Journal: Journal of medicinal chemistry
Published: April 15, 2025
Structural reorganization of high-entropy alloy CoNiCuMoZn for enhanced hydrogen evolution performance.
Journal: Journal of colloid and interface science
Published: February 17, 2025
Development of Peptide Paratope Mimics Derived from the Anti-ROR1 Antibody and Long-Acting Peptide-Drug Conjugates for Targeted Cancer Therapy.
Journal: Journal of medicinal chemistry
Published: June 29, 2024
Development and optimization of the Glabridin-loaded dissolving microneedle for enhanced treatment of keloid.
Journal: International journal of pharmaceutics: X
Published: April 28, 2024
An updated patent review of GPR40/ FFAR1 modulators (2020 - present).
Journal: Expert opinion on therapeutic patents
Published: November 10, 2023
Licochalcone A induces G2/M phase arrest and apoptosis via regulating p53 pathways in esophageal cancer: In-vitro and in-vivo study.
Journal: European journal of pharmacology
Published: July 31, 2023
Discovery of the First-in-Class Intestinal Restricted FXR and FABP1 Dual Modulator ZLY28 for the Treatment of Nonalcoholic Fatty Liver Disease.
Journal: Journal of medicinal chemistry
Published: April 20, 2023
Novel Co3O4@TiO2@CdS@Au double-shelled nanocage for high-efficient photocatalysis removal of U(VI): Roles of spatial charges separation and photothermal effect.
Journal: Journal of hazardous materials
Published: January 09, 2023
Discovery of a structurally novel, potent, and once-weekly free fatty acid receptor 1 agonist for the treatment of diabetes.
Journal: European journal of medicinal chemistry
Published: June 28, 2022
Discovery of the first-in-class dual PPARδ/γ partial agonist for the treatment of metabolic syndrome.
Journal: European journal of medicinal chemistry
Published: July 09, 2021
Discovery of new and highly effective quadruple FFA1 and PPARα/γ/δ agonists as potential anti-fatty liver agents.
Journal: European journal of medicinal chemistry
Published: May 04, 2021
Last Updated: 09/26/2026